银屑病关节炎滑膜免疫病理:细胞与分子见解
本综述探讨滑膜研究如何推进对银屑病关节炎的理解,重点介绍高维技术鉴定的巨噬细胞、成纤维细胞和肥大细胞亚群及IL-36、IL-41等细胞因子在发病中的作用,并讨论其作为生物标志物和治疗靶点的潜力,以及高维研究样本量有限阻碍临床转化的问题。
要点
- 银屑病关节炎与类风湿关节炎滑膜炎症的分子和细胞特征不同。
- 高维技术鉴定出银屑病关节炎特异性巨噬细胞、成纤维细胞和肥大细胞亚群。
- IL-36和IL-41等细胞因子驱动银屑病关节炎发病,可能成为治疗靶点。
核心结论
- 滑膜研究增进了对银屑病关节炎发病机制的理解,所鉴定的细胞类型和细胞因子有潜力作为生物标志物和新型治疗靶点。
- 高维研究中样本量有限正阻碍临床转化。
研究设计与样本
- 综述,探讨银屑病关节炎滑膜研究进展。
主要发现
- 高维技术研究鉴定出银屑病关节炎特异性巨噬细胞、成纤维细胞和肥大细胞亚群。
- 鉴定出IL-36和IL-41等特定细胞因子驱动银屑病关节炎发病。
局限性
- 高维研究中样本量有限正阻碍临床转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although psoriatic arthritis and rheumatoid arthritis are both common types of inflammatory arthritis characterised by synovial inflammation, there are distinct molecular and cellular landscapes between these conditions. Recent advances in synovial research in psoriatic arthritis have begun to unlock important insights into disease pathogenesis and potential clinical applications. For example, studies using high-dimensional technologies have identified psoriatic arthritis-specific macrophage, fibroblast, and mast cell subsets, as well as specific cytokines, such as IL-36 and IL-41, that drive pathogenesis. This Review explores how research of the synovium has advanced the understanding of psoriatic arthritis, the potential of identified cell types and cytokines as biomarkers and novel therapeutic targets, how limited sample sizes in high-dimensional studies are hindering clinical translation, and the future directions for synovial research in psoriatic arthritis.
引用
- Hum RM, Christofi M, Smith SL, et al. Synovial immunopathology in psoriatic arthritis: cellular and molecular insights. Lancet Rheumatol. 2025. PMID: 41043452. doi:10.1016/S2665-9913(25)00231-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。